Ertugliflozin for Type 2 Diabetes

被引：2
|
作者：
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2018年 / 319卷 / 23期
关键词：
D O I：
10.1001/jama.2018.5840
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2434 / 2435
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of ertugliflozin in patients with type 2 diabetes inadequately controlled with metformin monotherapy: VERTIS MET trial
    Charbonnel, B.
    Pascu, R.
    Frias, J.
    Pall, D.
    Saur, D.
    Darekar, A.
    Huyck, S.
    Shi, H.
    Lauring, B.
    Terra, S.
    Rosenstock, J.
    [J]. DIABETOLOGIA, 2017, 60 : S406 - S407
  • [42] Effectiveness and safety of ertugliflozin for type 2 diabetes: A meta-analysis of data from randomized controlled trials
    Zhang, Fudan
    Wang, Wenting
    Hou, Xu
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (03) : 478 - 488
  • [43] Efficacy and Safety of Ertugliflozin Added to Metformin: A Pooled Population from Asia with Type 2 Diabetes and Overweight or Obesity
    Linong Ji
    Jie Liu
    Zhi Jin Xu
    Zhiqi Wei
    Ruya Zhang
    Seema Malkani
    Nilo B. Cater
    Robert Frederich
    [J]. Diabetes Therapy, 2023, 14 : 319 - 334
  • [44] Role of Ertugliflozin in the Management of Diabetes Mellitus
    Totade, Manisha
    Gaidhane, Shilpa A.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (11)
  • [45] Population Pharmacokinetic (POPPK) Model for Ertugliflozin in Healthy Subjects and Type 2 Diabetes Mellitus (T2DM) Patients
    Fediuk, Daryl J.
    Sweeney, Kevin
    Zhou, Susan
    Kumar, Vikas
    Sahasrabudhe, Vaishali
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S25 - S25
  • [46] Efficacy and Safety of Ertugliflozin Added to Metformin: A Pooled Population from Asia with Type 2 Diabetes and Overweight or Obesity
    Ji, Linong
    Liu, Jie
    Xu, Zhi Jin
    Wei, Zhiqi
    Zhang, Ruya
    Malkani, Seema
    Cater, Nilo B.
    Frederich, Robert
    [J]. DIABETES THERAPY, 2023, 14 (2) : 319 - 334
  • [47] Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study
    Grunberger, George
    Camp, Sarah
    Johnson, Jeremy
    Huyck, Susan
    Terra, Steven G.
    Mancuso, James P.
    Jiang, Zhi Wei
    Golm, Gregory
    Engel, Samuel S.
    Lauring, Brett
    [J]. DIABETES THERAPY, 2018, 9 (01) : 49 - 66
  • [48] Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study
    Hollander, Priscilla
    Liu, Jie
    Hill, Julie
    Johnson, Jeremy
    Jiang, Zhi Wei
    Golm, Gregory
    Huyck, Susan
    Terra, Steven G.
    Mancuso, James P.
    Engel, Samuel S.
    Lauring, Brett
    [J]. DIABETES THERAPY, 2018, 9 (01) : 193 - 207
  • [49] Efficacy of ertugliflozin in monotherapy or combination therapy in patients with type 2 diabetes: A pooled analysis of placebo-controlled studies
    Liu, Jie
    Tarasenko, Lisa
    Terra, Steven G.
    Huyck, Susan
    Wu, Larry
    Pong, Annpey
    Calle, Roberto A.
    Gallo, Silvina
    Darekar, Amanda
    Mancuso, James P.
    [J]. DIABETES & VASCULAR DISEASE RESEARCH, 2019, 16 (05): : 415 - 423
  • [50] Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia
    Ji, Linong
    Liu, Yanmei
    Miao, Heng
    Xie, Yongli
    Yang, Ming
    Wang, Wei
    Mu, Yuting
    Yan, Ping
    Pan, Sharon
    Lauring, Brett
    Liu, Shu
    Huyck, Susan
    Qiu, Yanping
    Terra, Steven G.
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (06): : 1474 - 1482
12345